Modulating local airway immune responses to treat allergic asthma: lessons from experimental models and human studies

With asthma affecting over 300 million individuals world-wide and estimated to affect 400 million by 2025, developing effective, long-lasting therapeutics is essential. Allergic asthma, where Th2-type immunity plays a central role, represents 90% of child and 50% of adult asthma cases. Research base...

Descripción completa

Detalles Bibliográficos
Autores principales: Voskamp, A.L., Kormelink, T. Groot, van Wijk, R. Gerth, Hiemstra, P.S., Taube, C., de Jong, E.C., Smits, Hermelijn H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066288/
https://www.ncbi.nlm.nih.gov/pubmed/32020335
http://dx.doi.org/10.1007/s00281-020-00782-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066288/
https://www.ncbi.nlm.nih.gov/pubmed/32020335
http://dx.doi.org/10.1007/s00281-020-00782-4

Ejemplares similares